| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Lusutrombopag |
蘆曲泊帕 |
1110766-97-6 |
詳細
|
| 680C91 |
680C91 |
163239-22-3 |
詳細
|
| IRAK-1/4 INHIBITOR I |
IRAK-1-4 抑制劑 I |
509093-47-4 |
詳細
|
| (E)-3-(2-(1H-tetrazol-5-yl)vinyl)-6-fluoro-1H-indole |
(E)-3-(2-(1H-四氮唑-5-基)乙烯基)-6-氟-1H-吲哚 |
1316695-35-8 |
詳細
|
| STING agonist-1 |
702662-50-8 |
702662-50-8 |
詳細
|
| 4-bromo-phenyl-(4-phenyl-thiazol-2-yl)-amine |
N-(4-溴苯基)-4-苯基噻唑-2-胺 |
108237-91-8 |
詳細
|
| SPDB |
SPDB |
115088-06-7 |
詳細
|
| NS-398 |
抑制劑 |
123653-11-2 |
詳細
|
| PF 05105679 |
PF 05105679 |
1398583-31-7 |
詳細
|
| CDN 1163 |
4-異丙氧基-N-(2-甲基喹啉-8-基)苯甲酰胺 |
892711-75-0 |
詳細
|
| 5-[[4,5-Dimethoxy-2-(methylethyl)phenyl]methyl]-2,4-pyrimidinediamine |
5-[[4,5-Dimethoxy-2-(methylethyl)phenyl]methyl]-2,4-pyrimidinediamine |
1026582-88-6 |
詳細
|
| (3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester |
(3S,6S,12aS)-1,2,3,4,6,7,12,12a-八氫-9-甲氧基-6-(2-甲基丙基)-1,4-二氧代吡嗪并[1',2':1,6]吡啶并[3,4-b]吲哚-3-丙酸叔丁酯 |
461054-93-3 |
詳細
|
| KM 11060 |
7-氯-4-[4-[(4-氯苯基)磺?；鵠-1-哌嗪基]喹啉 |
774549-97-2 |
詳細
|
| ML418 |
ML418 |
1928763-08-9 |
詳細
|
| TP-003 |
TP-003 |
628690-75-5 |
詳細
|
| N-((4-(4-phenylpiperazin-1-yl)tetrahydro-2H-pyran-4-yl)methyl)-2-(phenylthio)nicotinamide |
N-[[4-(4-PHENYLPIPERAZIN-1-YL)OXAN-4-YL]METHYL]-2-PHENYLSULFANYLPYRIDINE-3-CARBOXAMIDE |
1428327-31-4 |
詳細
|
| ML335 |
化合物ML335 |
825658-06-8 |
詳細
|
| 2-(4-Chlorophenoxy)-2-methyl-N-[5-[(methylsulfonyl)amino]tricyclo[3.3.1.13,7]dec-2-yl]-propanamide |
2-(4-Chlorophenoxy)-2-methyl-N-[5-[(methylsulfonyl)amino]tricyclo[3.3.1.13,7]dec-2-yl]-propanamide |
878489-28-2 |
詳細
|
| NS 3623 |
NS 3623 |
343630-41-1 |
詳細
|
| 6-tert-butyl-2-(furan-2-carboxaMido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid |
CACCINH-A01 |
407587-33-1 |
詳細
|
| DPO-1 |
KV1.5阻斷劑, DPO-1 |
43077-30-1 |
詳細
|
| NS8593 HYDROCHLORIDE |
NS8593 鹽酸鹽 |
875755-24-1 |
詳細
|
| Verdinexor (KPT-335) |
Verdinexor (KPT-335) |
1392136-43-4 |
詳細
|
| JT010 |
JT010 |
917562-33-5 |
詳細
|
| BENZAMIL HYDROCHLORIDE |
BENZAMIL HYDROCHLORIDE |
2898-76-2 |
詳細
|
| (Z)-3-(3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazol-1-yl)-1-(3,3- |
KPT-276 |
1421919-75-6 |
詳細
|
| LX-4211 |
索格列凈 |
1018899-04-1 |
詳細
|
| N-(3-Aminopropyl)-2-[(3-methylphenyl)methoxy]-N-(2-thienylmethyl)benzamidehydrochloride |
AMTB鹽酸鹽 |
926023-82-7 |
詳細
|
| Methanone, [4-[(3-fluorophenyl)methoxy]-3-methoxyphenyl][4-[1-[(3-fluorophenyl)methyl]-1H-benzimidazol-2-yl]-1-piperidinyl]- |
化合物CRMP2-UBC9-V1.7 INHIBITOR 194 |
2241651-99-8 |
詳細
|
| PF03716556 |
PF03716556 |
928774-43-0 |
詳細
|
| Tariquidar |
N-[2-[[4-[2-(6,7-二甲氧基-3,4-二氫-1H-異喹啉-2-基)乙基]苯基]氨基甲?；鵠-4,5-二甲氧基苯基]喹啉-3-甲酰胺 |
206873-63-4 |
詳細
|
| TRPC6 inhibitor |
4-[[(1R,2R)-2-[(3R)-3-氨基-1-哌啶基]-2,3-二氫-1H-茚-1-基]氧基]-3-氯苯甲腈二鹽酸鹽 |
1333207-63-8 |
詳細
|
| KPT-330 |
塞利尼索 KPT330(Selinexor) |
1393477-72-9 |
詳細
|
| E-4031 |
N-[4-[[1-[2-(6-甲基-2-吡啶基)乙基]-4-哌啶基]羰基]苯基]甲烷磺酰胺二鹽酸鹽 |
113559-13-0 |
詳細
|
| BI 01383298 |
BI 01383298 |
2227549-00-8 |
詳細
|
| Canagliflozin heMihydrate |
卡格列凈半水合物 |
928672-86-0 |
詳細
|
| Loxoprofen sodium |
洛索洛芬鈉 |
80382-23-6 |
詳細
|
| MSA-2 |
MSA-2 |
129425-81-6 |
詳細
|
| BENZAMIL HYDROCHLORIDE |
3,5-二氨基-N-[(E)-氨基(芐基氨基)亞甲基]-6-氯-2-吡嗪甲酰胺鹽酸鹽(1:1) |
161804-20-2 |
詳細
|
| Canagliflozin |
卡格列凈 |
842133-18-0 |
詳細
|
| GI 254023X |
(ALPHAR)-N-[(1S)-2,2-二甲基-1-[(甲基氨基)羰基]丙基]-ALPHA-[(1S)-1-(甲?；u基氨基)乙基]苯戊酰胺 |
260264-93-5 |
詳細
|
| TAK-438 |
富馬酸沃諾拉贊 |
1260141-27-2 |
詳細
|
| Rhodamine 123 |
羅丹明 123 |
62669-70-9 |
詳細
|
| Suxibuzone |
琥布宗 |
27470-51-5 |
詳細
|
| H-151 |
H-151 |
941987-60-6 |
詳細
|
| 1-(2,4-dichlorobenzyl)indazole-3-carbohydrazide |
1-(2,4-二氯芐基)-1H-吲唑-3-碳酰肼 |
252025-52-8 |
詳細
|
| Lumacaftor (VX-809) |
魯瑪卡托 |
936727-05-8 |
詳細
|
| CP-456773 sodium |
N-[[(1,2,3,5,6,7-六氫-S-引達省-4-基)氨基]羰基]-4-(1-羥基-1-甲基乙基)-2-呋喃磺酰胺單鈉鹽 |
256373-96-3 |
詳細
|
| PF-04971729 |
埃格列凈 |
1210344-57-2 |
詳細
|
| TICAGRELOR |
替格瑞洛 |
274693-27-5 |
詳細
|
| SGI-1027 |
SGI-1027 |
1020149-73-8 |
詳細
|
| GSK503 |
化合物GSK503 |
1346572-63-1 |
詳細
|
| A-196 |
1982372-88-2 |
1982372-88-2 |
詳細
|
| VX-11e |
VX11E |
896720-20-0 |
詳細
|
| Nitisinone |
尼替西農(nóng) |
104206-65-7 |
詳細
|
| IM-12 |
IM-12 |
1129669-05-1 |
詳細
|
| NSC632839 |
NSC632839hydrochloride |
157654-67-6 |
詳細
|
| TG101209 |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-14-4 |
詳細
|
| BN82002 |
396073-89-5 |
396073-89-5 |
詳細
|
| GSK126 |
GSK126 |
1346574-57-9 |
詳細
|
| P005091 |
P005091 |
882257-11-6 |
詳細
|
| PFI-2 hydrochloride |
1627607-87-7 |
1627607-87-7 |
詳細
|
| XMD8-92 |
2-[[2-乙氧基-4-(4-羥基-1-哌啶基)苯基]氨基]-5,11-二氫-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮雜卓-6-酮 |
1234480-50-2 |
詳細
|
| Mocetinostat |
N-(2-氨基苯基)-4-([[4-(吡啶-3-基)嘧啶-2-基]氨基]甲基)苯甲酰胺 |
726169-73-9 |
詳細
|
| Fosphenytoin disodium |
磷苯妥英鈉 |
92134-98-0 |
詳細
|
| OICR-9429 |
OICR-9429 |
1801787-56-3 |
詳細
|
| JNJ0966 |
JNJ0966 |
315705-75-0 |
詳細
|
| MALT1 inhibitor MI-2 |
2-氯-N-[4-[5-(3,4-二氯苯基)-3-(2-甲氧基乙氧基)-1H-1,2,4-三唑-1-基]苯基]乙酰胺 |
1047953-91-2 |
詳細
|
| BIO-acetoxime |
6-溴靛玉紅-3'-丙酮肟 |
667463-85-6 |
詳細
|
| EI1 |
6-氰基-N-[(1,2-二氫-4,6-二甲基-2-氧代-3-吡啶基)甲基]-1-(1-乙基丙基)-1H-吲哚-4-甲酰胺 |
1418308-27-6 |
詳細
|
| Tofacitinib |
托法替尼 |
477600-75-2 |
詳細
|
| 2-D08 |
化合物2-D08 |
144707-18-6 |
詳細
|
| Gandotinib |
LY 2784544 |
1229236-86-5 |
詳細
|
| Tegobuvir |
5-[[6-[2,4-雙(三氟甲基)苯基]-3-噠嗪基]甲基]-2-(2-氟苯基)-5H-咪唑并[4,5-C]吡啶 |
1000787-75-6 |
詳細
|
| Pepstatin A |
抑肽素 A |
26175-03-3 |
詳細
|
| Orlistat |
奧利司他 |
96829-58-2 |
詳細
|
| 4-[3-(Trifluoromethyl)-2-pyridinyl]-N-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinecarboxamide |
4-(3-(三氟甲基)吡啶-2-基)-N-(5-三氟甲基)吡啶-2-基)哌嗪-1-甲酰胺 |
821768-06-3 |
詳細
|
| Elagolix Sodium |
惡拉戈利鈉 |
832720-36-2 |
詳細
|
| 5-(3-Bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one |
化合物5-BDBD |
768404-03-1 |
詳細
|
| Temocapril hydrochloride |
鹽酸替莫普利 |
110221-44-8 |
詳細
|
| ND-630 |
GS0976,ND-630 |
1434635-54-7 |
詳細
|
| Afimoxifene |
阿非昔芬 |
68392-35-8 |
詳細
|
| Prostaglandin E2 |
地諾前列酮 |
363-24-6 |
詳細
|
| Guanfacine hydrochloride |
鹽酸胍法辛 |
29110-48-3 |
詳細
|
| L67 |
|
325970-71-6 |
詳細
|
| Abiraterone |
阿比特龍 |
154229-19-3 |
詳細
|
| Ostarine |
OSTARINE(MK-2866) |
841205-47-8 |
詳細
|
| Cetilistat |
新利司他 |
282526-98-1 |
詳細
|
| Verbascoside |
毛蕊花糖苷 |
61276-17-3 |
詳細
|
| 4-HYDROXYTAMOXIFEN |
4-羥基三苯氧胺 |
68047-06-3 |
詳細
|
| Gemcitabine hydrochloride |
鹽酸吉西他濱 |
122111-03-9 |
詳細
|
| LOC-14 |
2-((4-(環(huán)丙烷羰基)哌嗪-1-基)甲基)苯并[D]異噻唑-3(2H)-酮 |
877963-94-5 |
詳細
|
| Valproic acid (sodium)(2:1) |
雙丙戊酸鈉 |
76584-70-8 |
詳細
|
| Plerixafor |
普樂沙福 |
110078-46-1 |
詳細
|
| Abiraterone acetate |
乙酸阿比特龍酯 |
154229-18-2 |
詳細
|
| XCT 790 |
3-[4-[[2,4-二(三氟甲基)芐基]氧基]-3-甲氧基苯基]-2-氰基-N-(5-三氟甲基-[1,3,4]噻二唑-2-基)丙烯酰胺 |
725247-18-7 |
詳細
|
| BAZEDOXIFENE ACETATE |
醋酸巴多昔芬 |
198481-33-3 |
詳細
|
| DexmedetomidineHclC13H16N2.Hcl |
右美托咪定 |
113775-47-6 |
詳細
|
| 7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine |
GSK2606414 |
1337531-36-8 |
詳細
|
| N-(2-(2-(4-chlorophenyl)thiazol-4-yl)ethyl)butyraMide |
N-[2-[2-(4-氯苯基)-4-噻唑基]乙基]丁酰胺 |
932986-18-0 |
詳細
|